The guidance document provides recommendations for identifying an optimized dosage for radiopharmaceutical therapies for ...

FDA’s recommendation to control 7-OH products under the Controlled Substances Act should help prevent competition between ...

Pharmaceutical Technology® spoke with C. Michael White, distinguished professor and Chair of the Department of Pharmacy Practice at the UConn School of Pharmacy and chair of the Kratom Consumer ...

The company will highlight how its GMP services combine engineering, consulting, equipment qualification, and facility ...

Dave Miller, PhD, explains how early formulation planning, novel platforms, and tailored approaches secure long-term protection against generics.

Based on an analysis done by the European Medicines Agency on the feasibility of alternatives, the European Commission ...

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...

Dave Miller, PhD, discusses how shifting drug manufacturing to domestic CDMOs can improve quality, reduce rework, and enhance ...

The company’s expanded label for Avtozma (tocilizumab-anoh) now includes the treatment of cytokine release syndrome, aligning ...

For the first target addressed in the partnership, the two companies reported the successful delivery of AI-designed, ...

The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing ...